Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS by Brasko, C. et al.
ORIGINAL ARTICLE
Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium
channels in oligodendrocytes, the myelinating cells of the CNS
C. Brasko1 • V. Hawkins1 • I. Chacon De La Rocha1 • A. M. Butt1
Received: 3 March 2015 / Accepted: 1 February 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract The inwardly rectifying K? channel subtype
Kir5.1 is only functional as a heteromeric channel with
Kir4.1. In the CNS, Kir4.1 is localised to astrocytes and is
the molecular basis of their strongly negative membrane
potential. Oligodendrocytes are the specialised myelinating
glia of the CNS and their resting membrane potential
provides the driving force for ion and water transport that is
essential for myelination. However, little is known about
the ion channel profile of mature myelinating oligoden-
drocytes. Here, we identify for the first time colocalization
of Kir5.1 with Kir4.1 in oligodendrocytes in white matter.
Immunolocalization with membrane-bound Na?/K?-
ATPase and western blot of the plasma membrane fraction
of the optic nerve, a typical CNS white matter tract con-
taining axons and the oligodendrocytes that myelinate
them, demonstrates that Kir4.1 and Kir5.1 are colocalized
on oligodendrocyte cell membranes. Co-immunoprecipi-
tation provides evidence that oligodendrocytes and astro-
cytes express a combination of homomeric Kir4.1 and
heteromeric Kir4.1/Kir5.1 channels. Genetic knock-out and
shRNA to ablate Kir4.1 indicates plasmalemmal expres-
sion of Kir5.1 in glia is largely dependent on Kir4.1 and the
plasmalemmal anchoring protein PSD-95. The results
demonstrate that, in addition to astrocytes, oligodendro-
cytes express both homomeric Kir4.1 and heteromeric
Kir4.1/Kir5.1 channels. In astrocytes, these channels are
essential to their key functions of K? uptake and CO2/H
?
chemosensation. We propose Kir4.1/Kir5.1 channels have
equivalent functions in oligodendrocytes, maintaining
myelin integrity in the face of large ionic shifts associated
with action potential propagation along myelinated axons.
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Introduction
Glial cell function is largely determined by their expression
of a wide range of plasmalemmal potassium channels
(Verkhratsky and Steinha¨user 2000). The inwardly recti-
fying potassium channel subtype Kir4.1 is the dominant
K? channel in astrocytes (Kofuji and Newman 2004).
Studies using the global Kir4.1 knock-out and targeted
ablation have demonstrated the critical role for Kir4.1 in
the key astroglial function of potassium homeostasis (Ko-
fuji et al. 2000; Neusch et al. 2006; Djukic et al. 2007;
Seifert et al. 2009; Bay and Butt 2013). In addition,
astrocytes express multiple Kir subtypes and their func-
tional diversity is increased by the formation of both
homomeric and heteromeric channels (Hibino et al. 2010;
Butt and Kalsi 2006). Kir5.1 is an inwardly rectifying K?
channel subunit that forms functional heteromeric channels
with Kir4.1 (Konstas et al. 2003). Heteromeric Kir4.1/5.1
channels are highly pH sensitive and have biophysical
properties distinct from homomeric Kir4.1 channels
(Tanemoto et al. 2000; Pessia et al. 2001). Heteromeric
Kir4.1/Kir5.1 channels have been indicated in astrocytes of
the retrotrapezoid nucleus (RTN), where due to their spe-
cial pH/CO2 sensitivity they are important in chemore-
ception and contribute to respiratory drive (Mulkey and
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Wenker 2011). The relationship between expression of
Kir5.1 with the dominant astrocyte channel Kir4.1 is not
fully elucidated, but it is possible that homomeric Kir4.1
and heteromeric Kir5.1/Kir4.1 channels may be differen-
tially expressed in specific astroglial populations (Ishii
et al. 2003; Hibino et al. 2004).
The other main class of glia in the CNS are oligoden-
drocytes, which have the essential function of myelinating
axons that make up CNS white matter. In contrast to
astrocytes, the ion channel profile of mature myelinating
oligodendrocytes is unresolved. There is immunohisto-
chemical evidence that oligodendrocytes express Kir4.1
(Poopalasundaram et al. 2000; Kalsi et al. 2004), and a
study in the global Kir4.1 knock-out mouse demonstrates it
is essential for oligodendrocyte development and myeli-
nation (Neusch et al. 2001). However, oligodendroglial
expression of Kir4.1 is controversial (Hibino et al. 2004;
Tang et al. 2009), and Kir5.1 has not been studied previ-
ously in an oligodendroglial context. Here, we have
determined the expression of Kir5.1 and Kir4.1 in oligo-
dendrocytes in the white matter of the mouse cerebellum
and optic nerve, in comparison to astrocytes. The optic
nerve is a typical CNS white matter tract that contains the
axons of retinal ganglion cells and the glia that support
them and is ideal for examining myelinating oligodendro-
cytes (Butt et al. 2004). The results demonstrate that
oligodendrocytes, like astrocytes, express at least two
subsets of Kir channels, homomeric Kir4.1 channels and
heteromeric Kir4.1/5.1 channels. Oligodendroglial K?
channels are essential for myelin formation and integrity in
the face of depolarizing elements (Hawkins and Butt 2013;
Neusch et al. 2001; Menichella et al. 2006). The special
biophysical properties of homomeric Kir4.1 and hetero-
meric Kir4.1/Kir5.1 channels indicate they have distinct
physiological roles in maintaining oligodendrocyte func-
tion during the large shifts in K? and pH to which they are
exposed during action potential propagation.
Materials and methods
Experimental animals
All animals were killed by cervical dislocation, in accor-
dance with regulations issued by the Home Office of the
United Kingdom under the Animals (Scientific Procedures)
Act, 1986. The animals used were C57BL6/J wild type
strains and GFAP-EGFP, PLP-DsRed, Sox10-EGFP and
Kir4.1 knock out transgenic mouse strains: GFAP-EGFP
mice express enhanced green fluorescent protein (EGFP)
under the control of the astrocyte-specific glial fibrillary
acidic protein (GFAP) promoter (Nolte et al. 2001); PLP-
DsRed mice express DsRed under the control of the
oligodendrocyte-specific proteolipid protein (PLP) pro-
moter (Hirrlinger et al. 2005); Sox10-EGFP mice express
EGFP under the control of the Sox10 promoter, which in
the CNS is specific to oligodendrocyte lineage cells (Stolt
et al. 2006); the GFAP-EGFP and PLP-DsRed strains were
kindly provided by Frank Kirchhoff (Molecular Physiol-
ogy, University of Saarland, Homburg, Germany) and the
Sox10-EGFP by Bill Richardson (Wolfson Institute for
Biomedical Research, University College London, UK).
The Kir4.1 channel knock-out mice were originally gen-
erated by Kofuji et al. (2000), and were kindly provided by
Christian Steinha¨user (Institute of Cellular Neurosciences,
University of Bonn, Germany). Kir4.1 KO mice were kept
in a heterozygous background and genotyping was per-
formed to identify homozygous, heterozygous and wild
type offspring using the Mouse Tail Quick Extraction
Solutions (Biopioneer Inc) and PCR amplification, as pre-
viously described (Kofuji et al. 2000).
Optic nerve explant cultures
Optic nerve explant cultures were prepared from mice aged
postnatal day (P)7–11, as described previously (Hawkins
and Butt 2013). In brief, optic nerves were carefully dis-
sected and maintained in pre-warmed (37 C) and pre-
gassed (95 % O2/5 % CO2) dissecting media, constituted
of Dulbecco’s Modified Eagle Medium (DMEM) (Sigma)
medium, supplemented with 4 mM L-glutamate, 10 %
foetal bovine serum (FBS; Invitrogen) and 0.1 % gentam-
icin (Invitrogen, Life Technologies Ltd., Paisley). From
this point on optic nerves were kept under sterile conditions
and cut into 1–2 mm fragments in filter sterilized pre-
warmed dissecting media, using a scalpel blade. For further
dissociation, optic nerve fragments were triturated and
nerve fragments transferred onto laminin (Invitrogen) and
poly-l-ysine (Sigma) coated coverslips and incubated in
dissecting medium at 37 C in 95 % O2/5 % CO2 over-
night to allow the adhesion of the explants. After 24 h, the
dissecting media was substituted with a low serum (0.5 %)
modified Bottenstein and Sato (B&S) culture medium,
supplemented with 10 ng/ml recombinant human PDGF-
AA (R&D Systems) and 0.1 % gentamicin. After 3–4 days
in vitro (DIV) the medium was replaced to B&S media
supplemented with 0.5 mM dibutyryl cAMP for up to 10
DIV. Explanted cells were then cultured in B&S media
with 0.1 % gentamicin for up to 15 DIV, changing media
every 3–5 days.
Transfection
Optic nerve explant cultures were transfected at 10 DIV
with psiSTRIKE vectors containing GFP and either Kir4.1
siRNA (forward 50-ACCGCTCTTCTCTGCAACCTTTAA
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GTTCTCTAAAGGTTGCAGA-GAAGAGCTTTTTC-30,
reverse 50-TGCAGAAAAAGCTCTTCTCTGCAACCTTT
AGAG-AACTTAAAGGTTGCAGAGAAGAG-30), or for
scrambled control (forward 50-ACCGACCTTCCTCCTTT
T-AGTAAGTTCTCTACG-TAAAAGGAGGAAGGTCT
TTTTC-30, reverse 50-TGCAGAAA-AAGACCTTCCTC
CTTTTACGTAGAGAACTTACGTAAAAGGAGGAAG
GT-3), using LipofectamineTM 2000 reagent (Invitrogen)
according to the manufacturer’s instructions. Cells were
incubated at 37 C in 95 % O2/5 % CO2 and examined at
2 days post transfection and transfected cells were iden-
tified by expression of GFP.
Immunohistochemistry
Brain tissue and optic nerve explant cultures were fixed in
1 % paraformaldehyde in phosphate buffered saline (PBS,
pH 7.4); tissue was fixed for either 1 h at RT or overnight
at 4 C, and for 10 min for cultured cells on their cover-
slips, followed by washes in PBS. For sectioning, brain
tissues were placed in cryoprotectant (30 % w v-1 sucrose
in PBS) overnight at 4 C, then embedded in Cryo-M-Bed
(Bright Instruments Company Ltd.), before rapidly freezing
at -70 C, sectioning using a cryostat (10 lm; Leica
CM3050 S), and transference of sections onto Polysine
coated slides (Thermo-Scientific). A blocking stage was
performed by incubation in 5 % normal goat serum (NGS)
for 1 h at RT, followed by permeabilization in 5 % NGS
plus 0.2 % triton-X-100 in PBS. After blocking, samples
were incubated overnight at 4 C with primary antibodies
diluted in NGS-PBS: chicken anti-GFAP, 1:500 (Chemi-
con); mouse anti-APC (adenomatous polyposis coli) anti-
body [CC-1], 1:700 (Calbiochem); rabbit anti-Olig2, 1:700
(Millipore); rabbit anti-Kir4.1, 1:400 (Kalsi et al. 2004);
guinea-pig anti-Kir4.1, 1:300 (Alomone); rabbit anti-
Kir4.1, 1:300 (Alomone); rabbit anti-Kir5.1, 1:300 (Alo-
mone); goat anti-Kir5.1, 1:100 (Santa Cruz); mouse anti-
Na/K ATPase a1, 1:300 (Abcam); mouse anti-PSD-95,
1:300 (Thermo). After washes in PBS, tissues and cells
were incubated for 1 h at RT with the appropriate sec-
ondary antibodies: goat anti-rabbit 488Alexafluor, 1:400
(Molecular Probes); donkey anti-goat 488Alexafluor, 1:400
(Molecular Probes); goat anti-guinea-pig 568Alexafluor,
1:500 (Life Technologies); donkey anti-chicken
568Alexafluor, 1:400 (Molecular Probes); donkey anti-goat
647Dylight, 1:200 (Stratech); donkey anti-chicken
405Dylight, 1:400 (Stratech); donkey anti-rabbit 647Dylight,
1:200 (Stratech); donkey anti-mouse 647Dylight, 1:200
(Stratech). Hoechst Blue (0.2 lg/ml; Molecular Probes)
was used to identify nuclei. Control experiments were
carried out in which sections/cells were preabsorbed with
antigen peptide overnight prior to incubation in the primary
antibody, or where antigen peptide was not available
controls were carried out by omitting primary antibody,
and Kir4.1 antibodies were tested in sections/cells from
Kir4.1 KO mice. Following immunolabeling, cover-
slips/sections were mounted with Vectasheild (Vec-
torLabs) and images acquired using a Zeiss meta LSM 710
confocal microscopes (Zeiss), maintaining variables con-
stant between images (see below).
Image capture and analysis
Fluorescence was detected using excitation wavelengths
of 488 nm (green), 568 nm (red), 633 nm (far red) and
405 nm (blue), with an argon, HeNe1 and diode laser,
respectively. Confocal images were captured using the
409 or 639 oil immersion objectives (numerical aper-
tures of 1.3 and 1.4, respectively), and images acquired
using multi-track sequential capture, with optimal
detector gain and offset acquisition settings for pinhole
diameter 0.13–0.3 airy units, with an average of four
scans per image, to detect positive signal with minimal
background and prevent cross-talk between channels.
Identical settings were used to image negative controls.
Z-stacks were captured of 4–15 z-sections (voxel size
43–76 nm x–y, 76–283 nm z). Image analysis was carried
out using Volocity 6.1 software (Improvision Ltd.). For
confocal photomicrographs, two-dimensional flattened
images of the z-stacks are presented. For colocalization
analyses, the technique of Barlow and colleagues was
used (Barlow et al. 2010), as previously described
(Hawkins and Butt 2013), in which the degree of sepa-
ration between pixels from the red and green channels
was determined in single z-sections to provide mea-
surements of signal overlap. First, images were thresh-
olded to separate the positive signal (positive
immunolabelling) from background; threshold was
determined by measuring the background intensity value
for each channel in negative control sections and setting
the threshold as the mean background intensity plus three
standard deviations (averaged from a minimum of 6
images). The thresholded Pearson’s correlation coeffi-
cient (PCC) and Mandersons’ overlap coefficients (M1
and M2) were determined as previously described (Bar-
low et al. 2010), using Volocity 6.1 software; thresh-
olded PCC determines the statistical strength of the
linear relationship between fluorescent intensities from
the red and green channels, and the M1 and M2 overlap
coefficients provide accurate measurements of the true
degree of overlap of red and green. A colocalization
channel was generated from the thresholded PCC to
illustrate in three-dimensions the voxels in which the two
channels overlap with the same intensity.
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Western blot
Whole brains or optic nerves were dissected from P16–P40
mice and homogenised in buffer containing: 12.5 mM
NaCl; pH *8 2 mM Tris/HCl; 0.2 mM phenyl-methyl
sulphonyl fluoride (PMSF), distilled water and 19 com-
plete mini protease inhibitor cocktail (Roche), all kept on
ice. Samples were centrifuged at 12,000 rpm for 5 min at
4 C and the aspirated supernatant was placed in a fresh
tube on ice. Quantification of protein concentration was
carried out with bicinchoninic acid assay (Sigma) with a
standard bovine serum albumin (BSA) concentration curve
and UV spectrophotometer absorbance readings at 550 nm.
Samples were mixed with Laemmli sample buffer and
heated at 95 C for 5 min with b-mercaptoethanol (except
samples used for the identification of Na?/K? ATPase a1
subunit, which were heated to 65 C according to the
manufacturers recommendation) and loaded for 10 %
acrylamide sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE), submerged in electrophore-
sis buffer pH *8 containing 25 mM Tris base 190 mM
glycine 0.1 %. Proteins were then electrophoretically
transferred to a polyvinyllidene difluoride membrane
(Amersham) that had been incubated for 1 h in blocking
solution containing of 5 % dried milk in Tris buffered
saline (TBS; 150 mM NaCl 10 mM Tris pH 7.4) with
0.05 % Tween 20. Incubation in primary antibodies diluted
in 5 % dried milk and Tris buffered saline: rabbit anti-
Kir4.1, 1:1000 (Kalsi et al. 2004), rabbit anti-Kir5.1, 1:300
(Alomone), goat anti-Kir5.1, 1:300 (Santa Cruz), mouse
anti-Na/K ATPase a1, 1:3000 (Abcam), mouse anti-PSD-
95, 1:3000 (Thermo), whole serum anti-SAP-97, 1:500
(Amcam), rabbit anti-prohibitin, 1:300 (Abcam), goat anti-
calnexin, 1:300 (Abcam). Following washes, incubation in
horseradish peroxidase-conjugated secondary antibodies
diluted in 5 % dried milk and Tris buffered saline was
carried out for 1 h at RT: rabbit anti-goat, 1:3000 (Dako),
goat anti-mouse, 1:10 000 (Dako), swine anti-rabbit 1:2000
(Dako). Extensive washing of the membranes in TBS with
ice cold 0.05 % Tween20 was performed after each incu-
bation and immunocomplexes were revealed using an
enhanced chemiluminescence method (Amersham).
Isolation of plasma membrane fraction
Whole brains and optic nerves of wild type and Kir4.1 KO
animals were homogenised in subcellular fractionation
buffer containing 250 mM sucrose, 20 mM HEPES,
10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA,
1 DTT and 19 protease inhibitor cocktail. Samples were
centrifuged at 4 C with 750 G for 10 min to remove the
nuclear fraction. Supernatant was placed in a new Eppen-
dorf tube and centrifuged with 10,000g at 4 C two times
to remove the mitochondrial fraction. Supernatant was
placed in an ultracentrifuge tube and centrifuged with
40,000g at 4 C for 1 h. The supernatant was removed and
the pellet containing the crude plasma membrane fraction
was resuspended in 400 ll fractionation buffer using a 25
G needle and centrifuged at 40,000g at 4 C for 45 min and
then the pellet was resuspended in lysis buffer.
Immunoprecipation
Brains and optic nerve obtained from adult wild type mice
(P16–40) were homogenised as described above. For the
precipitation of the proteins lMACSTM Protein A/G
MicroBead kit was used (Miltenyi Biotec) according to the
manufacturers recommendations. In brief, homogenised
brain or optic nerve samples were centrifuged at 4 C with
10,000g 2 times to clean the homogenate from cell debris.
3 lg polyclonal- or 2 lg monoclonal antibody was added
to the proteins and incubated overnight at 4 C. In the case
of negative controls, proteins were mixed with the preab-
sorbed antibodies or for Kir4.1, Kir4.1 knock out tissue
was used. Then, Protein G MicroBeads were added to the
samples to magnetically label the immune complex (50 ll
if monoclonal antibody was used or 100 ll if polyclonal
antibody was used for the precipation). The samples were
then mixed and incubated for 30 min on ice. The new l
Column were placed in the magnetic field of the
lMACSTM separator and then prepared by rinsing with
200 ll of lysis buffer containing of 150 mM NaCl, 1 %
Triton X-100, 50 mM Tris HCl (pH 8.0), before the cell
homogenate was applied onto the column. The homogenate
run through the columns was washed with 200 ll lysis
buffer four times then with 100 ll of low-salt wash buffer
containing of 1 % NP-40, 50 mM Tris HCl (pH 8.0). To
prepare the elution of the immune complex 20 ll of pre-
heated (95 C) 1 9 Laemelli sample buffer was applied
onto the column and incubated for 5 min at RT. Next,
50 ll of pre-heated (95 C) 19 Laemmli sample buffer
was applied to the column matrix to elute the immune
complex. The drop on the column tip containing the eluted
immunoprecipitate was collected and stored on ice or at
-80 C until it was analyzed by SDS-PAGE.
Results
Oligodendrocytes and astrocytes express Kir4.1
and Kir5.1 in the brain
The Kir5.1 subunit forms functional channels as hetero-
mers with Kir4.1, hence Kir5.1 expression might be
expected to mirror that of Kir4.1 in the brain (Hibino et al.
2004). Kir4.1 is established as the main Kir subunit in
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astrocytes and is highly expressed in the cerebellum (Tang
et al. 2009). In contrast, oligodendroglial expression of
Kir4.1 is poorly defined, but they are reported to be
immunopositive in the cerebellum (Poopalasundaram et al.
2000). Therefore, we assessed the expression of Kir5.1 in
comparison with Kir4.1 in cerebellar astrocytes and
oligodendrocytes (Fig. 1). Double immunofluorescence
labeling demonstrated extensive colocalization between
GFAP and Kir4.1, with strong and distinctive
immunopositivity for Kir4.1 in the radial processes of
Bergmann glia extending from the Purkinje cell layer
through the molecular layer to the pia, together with
astrocyte somata and processes in the granule cell layer and
white matter (Fig. 1A). In contrast, the radial processes of
Bergmann glia were not delineated by Kir5.1 immunola-
belling, and Kir5.1 was most prominent in the granule cell
layer and included distinct co-localisation with GFAP in
astrocytes (Fig. 1C). The results indicate differential
expression of Kir4.1 and Kir5.1 in Bergmann glia and
cerebellar astrocytes. Expression of Kir4.1 and Kir5.1 in
oligodendrocytes was examined using the APC(CC1)
antibody (Bhat et al. 1996), Olig2 immunolabelling, and in
sections from mice that express EGFP under the control of
the oligodendrocyte-specific Sox10 promoter (Stolt et al.
2006); APC, Olig2 and Sox10 are essential for oligoden-
drocyte differentiation and their expression is routinely and
extensively used to identify oligodendrocytes (Bhat et al.
1996; Bay and Butt 2013; Lang et al. 2013; Azim et al.
2014; Fancy et al. 2014). Although neurons also express
APC, it does not appear to be recognized by the APC/CC1
antibody and may be a different isoform than found in
oligodendrocytes (Brakeman et al. 1999). Double
immunofluorescence labeling with APC(CC1) to label
oligodendrocyte somata (Fig. 1B, D) and immunolabelling
in Sox10-EGFP? cells (Fig. 1E, F) demonstrates local-
ization of Kir4.1 and Kir5.1 in oligodendrocytes of the
cerebellar white matter. Further evidence of oligoden-
droglial expression of Kir4.1 is provided by immunola-
belling with Olig2 (Fig. 1G). The results demonstrate
robust expression of Kir4.1 and Kir5.1 in oligodendrocytes
in the cerebellar white matter. No immunoreactivity was
detected in negative controls in sections from knock out
mouse for Kir4.1 (Fig. 1Aiv) and by preabsorbing the
primary antibody with antigen peptide for Kir5.1 (Fig. 1-
Civ). In addition, the specificity of the antibodies was
further confirmed by western blot analysis of total protein
lysates in the brain and optic nerve (Fig. 1I, J). For Kir4.1,
the predicted molecular weights of the monomeric 42 kDa,
heteromeric 80 kDa, and tetrameric 160 kDa channels
were identified in wild-type mice, and these were absent in
brain lysates from Kir4.1 knock-out mice (Fig. 1I). Wes-
tern blot for Kir5.1 was performed in wild type mice, with
a predicted molecular weight of 48 kDa, together with
bands at 36 kDa and 70 kDa, depending on the extent of
glycosylation of the cytoplasmic and membrane bound
channels (Hibino et al. 2004), and positive bands were
eliminated by the competitive peptide (Fig. 1J).
Localization of Kir4.1 and Kir5.1 in optic nerve
astrocytes and oligodendrocytes
The optic nerve is a typical myelinated CNS white tract and
immunolocalization of Kir4.1 has been clearly identified in
astrocytes and oligodendrocytes (Kalsi et al. 2004). We
therefore examined the relationships between Kir5.1 and
Kir4.1 in optic nerve glia, using transgenic reporter mice in
which EGFP is under the control of the astrocyte-specific
promoter for the human GFAP gene and DsRed is under the
control of the oligodendrocyte-specific PLP gene (Fig. 2).
Extensive immunostaining for Kir4.1 and Kir5.1 was loca-
lised both in transversely oriented astrocytes (Fig. 2A, B)
and longitudinal rows of oligodendrocytes (Fig. 2C, D).
Colocalization of fluorescence labelling is most frequently
presented as overlays of red and green channels, with areas of
yellow indicating colocalization (Fig. 2Aiv, Biv, Civ, Div).
To analyse this more accurately, we used the technique of
Barlow and colleagues (Barlow et al. 2010), to perform
quantification of the degree of colocalization betweenKir4.1
and Kir5.1 with GFAP-EGFP and PLP-DsRed on high res-
olution confocal z-sections (Bay and Butt 2013). In brief, the
background intensity measured in negative control sections
(averaged from a minimum of 6 images) was used to
threshold the images and determine the Pearson’s correlation
coefficients in single z-sections, from which colocalization
channels were generated. In this way, the colocalization
channel identifies the individual voxels in which the two
channels overlap with the same intensity (Fig. 2Av, Bv, Cv,
Dv). The results demonstrate optic nerve astrocytes and
oligodendrocytes express Kir5.1 and Kir4.1 throughout their
cell somata and processes.
Plasmalemmal expression of Kir4.1 and Kir5.1
subunits in optic nerve glia
To be functional, Kir4.1 and Kir5.1 subunits need to be
expressed in the plasmalemma and this was assessed by
two methods: immunocolocalization with the plasma
membrane marker Na?–K?-ATPase a1 subunit in optic
nerve glial explant cultures, and western blot analysis of
purified plasma membrane fractions (Fig. 3). Immunola-
belling of optic nerve explant cultures demonstrates Kir4.1
and Kir5.1 colocalise with Na?–K?-ATPase in both
GFAP-positive astrocytes (Fig. 3A, B) and PLP-positive
oligodendrocytes (Fig. 3C, D). Quantification of co-local-
ization, as described above, demonstrated significant co-
localisation of both Kir4.1 and Kir5.1 with Na?–K?-
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ATPase in astrocytes and oligodendrocytes (Fig. 3E, F).
Western blot analysis of plasmamembrane fractions com-
pared to total lysates confirmed plasmalemmal expression
of Kir5.1 and Kir4.1 subunits in the optic nerve (Fig. 3G,
H). Measurement of the density of the bands relative to b-
actin indicated a 3.9-fold enrichment of Kir5.1 in the optic
nerve plasma membrane fraction, compared to 2.1-fold
enrichment for Kir4.1; no bands were observed in the
negative controls, using the Kir4.1 knock-out mouse and
pre-incubation in the Kir5.1 blocking peptide. In addition,
PSD-95 clusters Kir channels in the cell membrane through
its interaction with their PDZ domains (Horio et al. 1997;
Tanemoto et al. 2002; Pegan et al. 2007), hence we used
co-immunprecipitation of total brain and optic nerve
lysates to determine whether PSD-has a role in anchoring
Kir4.1 and Kir5.1 in optic nerve glia (Fig. 3I, J). PSD-95
was co-immunoprecipitated with both Kir4.1 (Fig. 3I) and
Kir5.1 (Fig. 3J) in the brain and optic nerve; western blot
of the anti-PSD-95 antibody gave a dense band at the
bFig. 1 Expression of Kir4.1 and Kir5.1 in oligodendrocytes and
astrocytes in the cerebellum. Immunolabelling for Kir4.1 and Kir5.1,
in combination with GFAP for astrocytes (A, C), and APC/CC1 for
oligodendrocytes (B, D). Immunolabelling for Kir4.1 (E) and Kir5.1
(F) in mice in which EGFP is under the control of the oligodendro-
cyte-specific Sox10 promoter. G Double immunolabelling for Kir4.1
(red) and the oligodenrocyte-specific marker Olig2 (green). Insets in
Aiv and Civ illustrate negative controls, in the Kir4.1 KO mouse (Aiv)
and following preincubation with the Kir5.1 blocking peptide (Civ).
Scale bars 20 lm. Western blot analysis of the brain and optic and
nerve for Kir4.1 (I) and Kir5.1 (J); bands were absent in the negative
controls, in the Kir4.1 knock-out mouse (I) following preincubation in
the Kir5.1 blocking peptide (J)
Fig. 2 Expression of Kir4.1 and Kir5.1 in optic nerve oligodendro-
cytes and astrocytes. Immunolabelling for Kir4.1 (A, C) and Kir5.1
(B, D), in GFAP-GFP mice to identify astrocytes (A, B) and PLP-
DsRED mice to identify oligodendrocytes (C, D). Cellular expression
of Kir4.1 and Kir5.1 is demonstrated by the generation of colocal-
isation channels (Av, Bv, Cv, Dv) from confocal z-stacks (Aiv, Biv,
Civ, Div), and green and red channels of equal intensity appear
yellow. Scale bars 20 lm
Brain Struct Funct
123
Brain Struct Funct
123
predicted MW and no band was detected in the negative
controls, and no co-immunoprecipitiation with PSD-95 was
observed in the negative controls, using the knock-out
mouse for Kir4.1 (Fig. 3I) and blocking peptide for Kir5.1
(Fig. 3J). These results demonstrate Kir4.1 and Kir5.1
subunit expression in the glial plasmalemma and support a
role for PSD-95 in their membrane localization.
Co-localization of Kir4.1 and Kir5.1 in astrocytes
and oligodendrocytes
Unequivocal cellular colocalization of Kir4.1 and Kir5.1
was demonstrated in vitro, by double immunofluorescence
labelling with rabbit anti-Kir4.1 and goat anti-Kir5.1 anti-
bodies in GFAP-positive astrocytes (Fig. 4Ai) and PLP-
positive oligodendrocytes (Fig. 4Bi). Co-localisation anal-
ysis indicated both Kir4.1 homomeric and Kir4.1/Kir5.1
heteromeric channels in astrocytes (Fig. 4C) and oligo-
dendrocytes (Fig. 4D), and this was confirmed by co-im-
munoprecipitation in brain and optic nerve extracts, in both
directions, with Kir5.1 protein being detected in the Kir4.1
immunoprecipitate (Fig. 4E, lower lane), and Kir4.1 being
detected in the Kir5.1 immunoprecipate (Fig. 4F, lower
lane); immunoblotting was absent in negative controls,
using the knock out mouse for Kir4.1 (Fig. 4E) and
preincubation with the blocking peptide for Kir5.1
(Fig. 4F). The results were confirmed in 5 different
experiments and demonstrate that optic nerve glia express
heteromeric Kir4.1/Kir5.1 channels. In addition, there was
punctate Kir5.1 immunostaining that was not co-localised
with Kir4.1 within the cytoplasm of the somata and along
the processes of astrocytes (Fig. 4Avi–viii, arrows) and
oligodendrocytes (Fig. 4Bvi–viii, arrows).
Glial Kir5.1 is downregulated in the absence
of Kir4.1
The results presented above demonstrate astrocytes and
oligodendrocytes express heteromeric Kir4.1/Kir5.1
channels. To evaluate this further, we compared Kir5.1
immunolabelling in optic nerve explants from Kir4.1 ?/
? wild type mice (Fig. 5A) and Kir4.1-/- knock out mice
(Fig. 5B), and using shRNA to knock down Kir4.1 in optic
nerve glial explant cultures (Fig. 5D), compared to
scrambled shRNA vector in controls (Fig. 5C). We estab-
lished above that Kir4.1 is absent in brains and optic nerves
of Kir4.1 knock-out mice (Fig. 1). We found equivalent
results in optic nerve explants, with robust Kir4.1
immunolabelling in glia from wild-type mice (Fig. 5Ai,
inset) and absence of Kir4.1 immunolabelling in cells from
Kir4.1 knock-out mice (Fig. 5Bi, inset), which was con-
firmed by quantification (Fig. 5E). Similarly, Kir5.1
immunolabelling was strong in wild-type cells (Fig. 5A),
but in the absence of Kir4.1, there was a marked decrease
in Kir5.1 immunolabelling (Fig. 5B), which was statisti-
cally significant (Fig. 5F). In addition, we demonstrate that
knock-down of Kir4.1 with shRNA significantly reduced
the expression of Kir5.1 (Fig. 5D), whereas controls were
unaffected (Fig. 5C), as summarised in the histograms
(Fig. 5F); transfected cells were identified by GFP
expression and Kir5.1 expression was not significantly
different between wild-type and scrambled controls, or
between Kir4.1 knock out and Kir4.1 shRNA cells
(Fig. 5F). We confirmed the loss of Kir4.1 immunola-
belling following Kir4.1 knock-down (Fig. 5Di, inset),
whereas transfection with scrambled shRNA had no effect
on Kir4.1 (Fig. 5Ci, inset), and the results were statistically
significant (Fig. 5E).
Plasmalemmal Kir5.1 is decreased in the absence
of Kir4.1
Immunocolocalization with the plasma membrane marker
Na?–K?-ATPase a1 subunit (Fig. 6A–C), and western blot
analysis of the plasmamembrane fraction (Fig. 6D)
demonstrates a loss of plasmalemmal Kir5.1 in the absence
of Kir4.1. As in non-transfected cells shown above
(Fig. 3A–D), there was extensive co-localization of Kir5.1
and Na?–K?-ATPase in controls transfected with scram-
bled shRNA (Fig. 6A), whereas co-localisation was sig-
nificantly reduced following transfection with Kir4.1
shRNA (Fig. 6B), resulting in a twofold decrease in Kir5.1/
Na?–K?-ATPase colocalized voxels from 15.2 % in con-
trols to 7.1 % following Kir4.1 knock-down (Fig. 6C).
Similarly, western blot of the brain plasma membrane
fraction from wild-type and Kir4.1 knock-out mice
demonstrated a significant reduction in Kir5.1 levels by
60 ± 14 % in the absence of Kir4.1 (Fig. 6D, E). These
results demonstrate an overall decrease in Kir5.1 expres-
sion in the absence of Kir4.1 and a specific reduction in
plasmalemmal Kir5.1, providing evidence that the bulk of
glial Kir5.1 is expressed in the form of heteromeric
bFig. 3 Plasmalemmal expression of Kir4.1 and Kir5.1 subunit in
optic nerve glia. Immunolocalization of Kir4.1 and Kir5.1 with the
membrane bound Na–K-ATPase a1 subunit in optic nerve explants of
astrocytes identified by GFAP (A, B) and oligodendrocytes identified
by PLP-DsRed (C, D). Scale bars 20 lm. Quantification in astrocytes
and oligodendrocytes of total number of voxels immunopositive for
Kir4.1 and Kir5.1, compared to voxels that were identified as
colocalized for Kir4.1/Na–K-ATPase (E) and Kir5.1/Na–K-ATPase
(F); data are mean ± SEM, n = 13 cells for each analysis. Western
blot analysis of Kir5.1 (G) and Kir4.1 (H) in total optic nerve lysate
and plasma membrane fraction. Co-immunoprecipitation of Kir4.1
(I) and Kir5.1 (J) with PSD95, in total brain and optic nerve (ON)
lysate; negative controls were Kir4.1 knock-out mice (-/-) for
Kir4.1 and preincubation with the blocking peptide for Kir5.1
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channels with Kir4.1, and most of the remaining Kir5.1
subunits appear to be retained intracellulary and do not
form plasmalemmal channels in the absence of the Kir4.1.
Kir5.1 is decreased in myelin in the absence
of Kir4.1
Oligodendrocytes were very rarely transfected in our
in vitro experiments and so we examined interactions
between Kir5.1 and Kir4.1 in oligodendrocytes by
immunolabelling of optic nerve and brain sections from
Kir4.1 knock-out mouse. There is a complete loss of Kir4.1
immunolabeling in the knock-out mouse (Fig. 1Aiv), and
this results in an evident decrease in Kir5.1 immunola-
belling overall, as well as a specific decrease in Kir5.1 in
oligodendrocytes and myelin, as illustrated by MBP
immunolabelling in the optic nerve (Fig. 7A, B), and by
APC(CC1) immunolabeling in the corpus callosum
(Fig. 7C, D) and cerebellum (Fig. 7E, F). We showed
above by western blot a complete loss of Kir4.1 protein in
the knock-out mouse (Fig. 1I), and this resulted in signif-
icant decreases in Kir5.1 protein levels in the optic nerve
(Fig. 7G) and brain (Fig. 7H), by 33.5 ± 3.5 and
53 ± 0.4 %, respectively (Fig. 7I; p\ 0.001, unrelated
t test).
Discussion
The inward rectifying K? channel subtype Kir4.1 has been
considered to be almost exclusively astroglial in the CNS
(Hibino et al. 2004; Tang et al. 2009), and forms hetero-
meric channels with the Kir5.1 subunit in astrocytes from a
number of brain regions (Ishii et al. 2003; Hibino et al.
2004). Here, we demonstrate that oligodendrocytes, the
myelinating cells of the CNS, express plasmalemmal
homomeric Kir4.1 channels and heteromeric Kir4.1/Kir5.1
channels. Oligodendroglial expression of Kir4.1 has been
considered controversial (Tang et al. 2009), and is likely to
be heterogeneous (Poopalasundaram et al. 2000). Our study
demonstrates that Kir4.1 immunolabelling is colocalised
with multiple markers for oligodendrocytes: (1) the PLP-
DsRed reporter, (2) Sox10-eGFP reporter, (3) APC(CC1)
and (4) Olig2. Kir4.1 and Kir4.1/Kir5.1 channels have
distinct functions in astroglial K? transport and pH/CO2
chemosensation (Mulkey and Wenker 2011; Kofuji and
Newman 2004; Butt and Kalsi 2006; Olsen and Sontheimer
2008). Our results indicate the distinct properties of these
channels are important for the oligodendrocyte function of
myelination.
Oligodendrocytes and white matter astrocytes
express Kir4.1 and Kir4.1/5.1
Co-immunoprecipitation and immunolabeling identified
the existence of both homomeric Kir4.1 and heteromeric
Kir4.1/Kir5.1 channels in astrocytes and oligodendrocytes
of optic nerve and cerebellar white matter. The anti-Kir4.1
antibodies used in this study have been validated previ-
ously (Kalsi et al. 2004) and their specificity was confirmed
using western blot and immunohistochemistry in Kir4.1
knock-out mice, in support of previous studies using a
similar antibody (Kofuji et al. 2000; Neusch et al. 2001). In
the case of Kir5.1, the specificity of the antibodies was
confirmed by using blocking peptides and comparing two
commercially available antibodies from Alomone (rabbit
anti-rat Kir5.1 antibody) and Santa Cruz (goat anti-mouse
Kir5.1 antibody), raised againist two different non over-
lapping epitopes in the C-terminus of the channel. The two
antibodies provided equivalent immunoblot and immuno-
labeling results that were completely absent in the presence
of blocking peptide. Expression of Kir4.1 and Kir5.1 in
oligodendrocytes was verified in three ways: (1) in double
immunolabelling with the anti-APC(CC1) and Olig2 anti-
bodies—APC and Olig2 are essential for oligodenrocyte
differentiation and the CC1 antibody is used routinely and
extensively to identify oligodendrocytes in the CNS (Bhat
et al. 1996; Bay and Butt 2013; Lang et al. 2013; Azim
et al. 2014; Fancy et al. 2014); (2) immunolabelling in
sections from mice that express EGFP under the control of
the Sox10 promoter, which is a transcription factor that is
essential for oligodendrocyte differentiation and is
expressed by all oligodendrocyte lineage cells (Stolt et al.
2006; Azim et al. 2014); (3) immunolabelling in sections
and isolated cells from mice that express DsRed under the
control of the myelin protein PLP (Hirrlinger et al. 2005;
Azim et al. 2014). The results demonstrate expression of
Kir4.1 and Kir5.1 in astrocytes and oligodendrocytes, and
specifically plasmalemmal localisation of the Kir subunits
on glia by immunoblot of optic nerve plasma membrane
and immunocytochemical co-localisation with plasma
bFig. 4 Co-expression of Kir4.1 and Kir5.1 in optic nerve oligoden-
drocytes and astrocytes. Co-immunolocalization of Kir4.1 and Kir5.1
in optic nerve explant cultures, in astrocytes identified by GFAP
immunolabelling (A) and oligodendrocytes identified by PLP-DsRED
(B). The overlay and individual channels are illustrated, together with
the co-localisation channel for Kir4.1/Kir5.1 (Aii, Bii). Boxed areas
on overlay images (Ai, Bi) are enlarged in Avi–Aviii and Bvi–Bviii, to
illustrate punctate colocalization of Kir4.1 and Kir5.1 along processes
(some indicated by arrows). Scale bars 20 lm. Quantification of the
number of voxels that were positive for Kir4.1 and Kir5.1 alone and
of Kir4.1/Kir5.1 together, in astrocytes (C, n = 15) and oligoden-
drocytes (D, n = 13); data are mean ± SEM. Co-immunoprecipita-
tion of Kir4.1 with Kir5.1 (E) and of Kir5.1 with Kir4.1 (F) from total
brain and optic nerve (ON) lysates; negative controls were Kir4.1
knock-out mice (-/-) for Kir4.1, and using the blocking peptide for
Kir5.1
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membrane-bound Na–K-ATPase. Immunoblot analysis
demonstrated robust bands as predicted according to the
momomer subunit molecular weights, 42 kDa for Kir4.1
and 48 kDa for Kir5.1. In addition, bands for Kir4.1 were
indicated at 80 and 160 kDa, which corresponds to the
heteromeric and homo-tetrameric channel as observed
previously in the brain and retina (Kofuji et al. 2000;
Ulbricht et al. 2008). Furthermore, bands were detected at
70 kDa for Kir5.1, which were more enriched in the optic
nerve plasma membrane fraction, and are consistent with
previous findings indicating the ion channel is regulated by
glycosylation (Ishii et al. 2003). A key finding was that the
co-immunoprecipitation and immunocytochemical analy-
ses indicated oligodendrocytes and astrocytes express
Kir4.1/Kir5.1 heteromers, with the majority of Kir5.1 being
associated with Kir4.1 and present in the plasmalemma,
which is essential for functional heteromeric channels.
Furthermore, examination of Kir4.1 knock-out mouse tis-
sue and using shRNA to ablate Kir4.1 in vitro demon-
strated that plasmalemmal Kir5.1 expression was almost
completely dependent on Kir4.1. In contrast, the bulk of
Kir4.1 ([80 %) in optic nerve glia was not co-expressed
with Kir5.1, indicating a predominance of homomeric
Kir4.1 channels.
Heterogeneity of glial Kir4.1 and Kir5.1 expression
Astroglial Kir4.1 and Kir5.1 immunolabelling was
heterogeneous in the brain and optic nerve, indicating that
most astrocytes expressed Kir4.1 and Kir5.1 to a high
degree, but a subpopulation were only weakly
immunopositive or possible immunonegative for Kir5.1, in
agreement with previous studies (Poopalasundaram et al.
2000; Hibino et al. 2004; Kalsi et al. 2004; Tang et al.
2009). In the cerebellum, Bergmann astroglia were dis-
tinctive in that their primary processes were strongly
decorated with Kir4.1, but not Kir5.1, whereas astrocytes
in the granule cell layer expressed Kir4.1 and Kir5.1.
White matter astrocytes were enriched with Kir4.1, which
is consistent with studies in knock-out mice demonstrating
Kir4.1 are essential for prominent astroglial inward cur-
rents and the uptake of K? released by axons during action
potential propagation (Kofuji et al. 2000; Neusch et al.
2006; Djukic et al. 2007; Seifert et al. 2009; Bay and Butt
2013). A prominent role for heteromeric Kir4.1/Kir5.1
channels in K? transport has also been demonstrated in
transporting epithelia, for example in the renal tubules and
gastric parietal cells (Paulais et al. 2011; Tanemoto et al.
2000; Tucker et al. 2000; Lachheb et al. 2008). Hetero-
meric Kir4.1/Kir5.1 channels are stronger inward rectifiers
than homomeric Kir4.1 channels, which provides a
potential mechanism for the uptake of K? at sites of high
activity via Kir4.1/Kir5.1 and release of K? at sites of low
activity via homomeric Kir4.1 channels (Kofuji et al. 2002;
Butt and Kalsi 2006; Bay and Butt 2013). The close
association of Kir4.1 and Kir5.1 with plasmalemmal Na?–
K?-ATPase suggests the targeting of these channels to the
same membrane microdomains may help provide K? for
the activity of the pumps, as observed for H?–K?-pumps
in parietal cells (Fujita et al. 2002; Kaufhold et al. 2008).
In the CNS, heterometric Kir4.1/Kir5.1 channels have been
described in retinal Mu¨ller cells, brain astrocytes derived
from neocortex, retrotrapezoid nucleus and the glomeruli
of the olfactory bulb, and brainstem neurons from the
cardio-respiratory nuclei (Hibino et al. 2004; Ishii et al.
2003; Tanemoto et al. 2000; Tucker et al. 2000; Wu et al.
2004; Yamamoto et al. 2008). Interestingly, a study using a
bacterial artificial chromosome (BAC) transgenic approach
to express EGFP under the transcriptional control of the
Kir4.1 promoter reported prominent expression of EGFP in
astrocytes but not oligodendrocytes (Tang et al. 2009). In
contrast, Kir4.1 have been detected in oligodendrocytes by
immunohistochemistry (Poopalasundaram et al. 2000;
Kalsi et al. 2004) and electrophysiological experiments
demonstrate prominent Kir in oligodendrocytes (Neusch
et al. 2001; Bolton and Butt 2006), and genetic ablation of
Kir4.1 results in a loss of Kir currents and causes severe
dysmyelination (Neusch et al. 2001). Our results demon-
strate that in white matter of the optic nerve and cerebel-
lum oligodendrocytes express heteromeric Kir4.1/Kir5.1
channels, as well as homomeric Kir4.1 channels, and we
show the loss of Kir4.1 is associated with a marked
reduction of Kir5.1 in oligodendrocytes and myelin, sup-
porting a role for these channels in oligodendroglial K?
regulation and myelin integrity (Neusch et al. 2001; Bolton
and Butt 2006; Menichella et al. 2006). The discrepancy in
the literature is likely to reflect the heterogeneity of
oligodendroglial expression of Kir4.1, which appears
greatest in the optic nerve, cerebellum and spinal cord,
whereas in the forebrain Kir4.1 is far more prominent in
protoplasmic astrocytes compared to oligodendrocytes
(Poopalasundaram et al. 2000; Neusch et al. 2001; Kalsi
et al. 2004).
bFig. 5 Glial Kir5.1 expression is reduced in the absence of Kir4.1
subunit. Immunolabelling for Kir5.1 was determined in optic nerve
explants cultures, comparing wild-type mice (A, Kir4.1?/?) with
Kir4.1 knock-out mice (B, Kir4.1-/-), and following transfection
with scrambled shRNA (C) or Kir4.1 shRNA (D); transfected cells
were identified by the expression of GFP (appears green) and insets
demonstrate Kir4.1 expression in controls (Ai, Ci) and complete
ablation in Kir4.1-/- mice (Bi) and Kir4.1 shRNA (Di). Scale bars
10 lm. Quantification of expression of Kir4.1 (E) and Kir5.1 (F) in
Kir4.1?/?, Kir4.1-/-, scrambled control and Kir4.1shRNA glia;
analysis was performed on 10–12 cells in each group, and data are
expressed as mean ± SEM number of voxels per lm3, ***p\ 0.001,
one-tailed t test
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Dependence of glial Kir5.1 expression on the Kir4.1
subunit
Genetic ablation of Kir4.1 or knock-down using shRNA
demonstrated that plasmalemmal expression of Kir5.1 in
astrocytes and oligodendrocytes was largely dependent on
its association with Kir4.1, consistent with clustering of
Kir5.1 in the plasma membrane through the PDZ domain of
the Kir4.1 subunit, which prevents internalisation of Kir5.1
(Konstas et al. 2003; Tanemoto et al. 2004). In addition, we
provide evidence that clustering of Kir4.1 and Kir5.1
involves the MAGUK family PDZ-binding anchoring
Fig. 6 Specific reduction in plasmalemmal Kir5.1 in the absence of
Kir4.1. Immunolocalization of Kir5.1 with the membrane bound Na–
K-ATPase a1 subunit in optic nerve explant astrocytes identified by
expression of GFAP, following transfection with scrambled shRNA
(A) or Kir4.1 shRNA (B); transfected cells were identified by co-
transfection with GFP (appears green) and the co-localization channel
indicates voxels in which Kir5.1 and Na–K-ATPase immunolabelling
was at the same intensity (Avi, Bvi). Scale bars 20 lm. C Quantifi-
cation of plasmalemmal Kir5.1 expressed as percentage of total
Kir5.1 ? voxels (data are mean ± SEM, n = 11–13 per group;
*p\ 0.05, one-tailed t test). D, E Western blot of Kir5.1 expression
in the brain plasma membrane fraction from Kir4.1?/? wild-type and
Kir4.1-/- knock-out mice (D) and mean (±SEM) integrated density
normalised against b-actin (E, n = 3, ***p\ 0.001, one-tailed t test)
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Fig. 7 Reduction of Kir5.1 in oligodendrocytes and myelin in the
absence of Kir4.1. Immunolocalization of Kir5.1 with myelin basic
protein, MBP (A, B) and the oligodenrocyte marker APC/CC1 (C–F),
in brain tissue from wild-type Kir4.1?/? mice (A, C, E) compared to
Kir4.1-/- knock-out mice (B, D, F). Scale bars 20 lm. Western blot
analysis of Kir5.1 from total lysates of optic nerve (G) and brain
(H) from wild-type Kir4.1?/? and Kir4.1-/- knock-out mice, and
mean (±SEM) integrated density normalised against b-actin (I,
n = 3, **p\ 0.01; ***p\ 0.001, one-tailed t test)
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proteins PSD-95, which has been described in other cells
(Horio et al. 1997; Tanemoto et al. 2002). Although Kir5.1
homomeric channels are generally thought to be non-
functional, there is evidence that clustering of Kir5.1 sub-
units by PSD-95 mediates the formation of functional
homomeric Kir5.1 channels in the brain (Tanemoto et al.
2002). We observed co-immunoprecipitation of Kir5.1
with PSD-95 in the optic nerve and a high degree of Kir5.1
immunolabelling in optic nerve glia was not associated
with Kir4.1, raising the possibility they may express
functional homomeric Kir5.1 channels. However, Kir5.1
may also form heteromers with other Kir subtypes,
including Kir2.1 (Derst et al. 2001; Pessia et al. 2001),
which is expressed by astrocytes (Horio 2001; Howe et al.
2008; Kang et al. 2008), and also clusters with PSD-95
(Fomina et al. 2011; Nehring et al. 2000; Leonoudakis
et al. 2001; Pegan et al. 2007). Our results identified that
Kir5.1 immunolabeling was mostly concentrated within the
cell cytoplasm, tenfold greater than at the plasmalemma,
indicating they provide a pool by which plasmallemal
Kir4.1/Kir5.1 channels could be inserted into the cell
membrane and provide dynamic regulation of the glial
membrane potential in response to changes in the
extracellular environment (Bolton and Butt 2006; Bolton
et al. 2006). Kir5.1 are known to display intracellular
localization and phosphorylation dependent interactions
result in the targeting of Kir5.1/Kir4.1 heteromeric chan-
nels to the membrane (Tanemoto et al. 2000, 2004, 2008).
Furthermore, Kir4.1/Kir5.1 channels are regulated by
multiple factors, including PKA, PIP2, pH and CO2 (Xu
et al. 2000; Yang et al. 2000; Rapedius et al. 2007; Rojas
et al. 2007, 2008). Hence, the cytoplasmic pool of Kir5.1
would allow astrocytes and oligodendrocytes to respond
rapidly to changes in the extracellular environment and
dynamically target heteromeric Kir4.1/Kir5.1 channels to
the cell membrane to provide channels with much stronger
rectification and pH/CO2 sensitivity than Kir4.1 homo-
meric channels (Tanemoto et al. 2000; Yang et al. 2000;
Pessia et al. 2001).
Functional implications of heteromeric Kir4.1/
Kir5.1 channels in oligodendrocytes
Kir5.1 co-assembles with Kir4.1 to form functional pH-
sensitive potassium channels (Yang et al. 2000; Cui et al.
2001; Pessia et al. 2001), which have been identified as
Fig. 8 Functional implications of homomeric Kir4.1 and heteromeric
Kir4.1/Kir5.1 channels in oligodendrocytes. Oligodendroglial expres-
sion of Kir4.1 channels indicates they may be important in uptake of
excess K? released during axonal action potential propagation, a
function largely attribiuted to astrocytes. Due to their wrapping of
axons, oligodendrocytes are exposed to large ionic and pH shifts
during axonal electrical activity, and it is likely weakly rectifying
homomeric Kir4.1 and strongly rectifying Kir4.1/Kir5.1 heteromeric
channels are important in maintaining the negative resting membrane
potential, which is essential for oligodendroglial and myelin integrity.
Weakly rectifying homomeric Kir4.1 channels may preferentially
extrude K? and supply extracellular K? for the Na?–K?-pumps, as
described in transporting epithelia. In contrast, the pH sensitivity of
heteromeric Kir4.1/Kir5.1 channels is likely to have a role in the CO2/
pH chemosensation in glia, involving carbonic anhydrase that is
enriched in astrocytes and oligodendrocytes. Furthermore, intracellu-
lar acidification and inhibition of Kir4.1/Kir5.1 channels has been
shown to trigger release of ATP from astrocytes, which would act on
oligodendroglial P2X and P2Y receptors to provide a mechanism of
astrocyte–oligodendrocyte signaling in response to metabolic chal-
lenges, which has important implications for white matter physiology
and pathology
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astroglial CO2 chemoreceptors in the chemosensitive
nuclei of the brainstem (Mulkey and Wenker 2011; Wu
et al. 2004; Wenker et al. 2012). In white matter, oligo-
dendrocytes are exposed to considerable ionic and pH
shifts that take place during intense and continuous action
potential propagation along axons (Kettenmann et al. 1990;
Ransom 1992). This places a high metabolic load on
oligodendrocytes and it is likely that Kir4.1/Kir5.1 chan-
nels in oligodendrocytes are involved in sensing changes in
pH/CO2, which could be important in maintaining their
RMP during metabolic stress (Fig. 8). As in other cells, a
primary role of weakly rectifying homomeric Kir4.1
channels would be to supply Na?–K? pumps, which is
essential for K? regulation by astrocytes and oligoden-
drocytes, whilst heteromeric Kir4.1/Kir5.1 channels would
be essential for pH/CO2 sensation due to their unique pH
sensitivity in the physiological range (Cui et al. 2001).
Astrocytes express carbonic anhydrase (CA) V, while
oligodendrocytes have CAII, which is critical for astroglial
and oligodendroglial H? regulation by the rapid conversion
of CO2 and H2O to H2CO3, which dissociates to HCO3
-
and H? coupled to plasmalemmal Na?–H?-exchange and
Na?-HCO3
- cotransport, as well as Na?-independent Cl-–
HCO3
--exchange (Kettenmann et al. 1990; Boussouf and
Gaillard 2000; Ro and Carson 2004). Kir4.1/Kir5.1 cur-
rents are regulated by CO2 and intracellular pH (Yang et al.
2000; Cui et al. 2001), hence inhibition of Kir4.1/Kir5.1
channels in response to intracellular acidification during
intense axonal electrical activity and high metabolic
demand would reduce inward K? currents and help main-
tain the oligodendroglial membrane potential, which is
essential for myelin integrity (Hawkins and Butt 2013).
Furthermore, in the retrotrapezoid nucleus of the central
chemoreceptors, inhibition of astroglial Kir4.1/Kir5.1 cur-
rents is the mechanism by which they sense an increase in
extracellular CO2 and this triggers the release of ATP from
astrocytes (Wenker et al. 2012). We have previously
demonstrated that optic nerve astrocytes release ATP in
response to axonal electrical activity (Hamilton et al. 2008,
2010) and astroglial ATP stimulates local blood flow (Butt
2011). Thus, astroglial Kir4.1/Kir5.1 channels provide a
mechanism by which they sense increased H?/CO2 during
axonal electrical activity and release ATP to increase local
blood flow and maintain axonal function. In addition, ATP
released by astrocytes would directly act on metabotropic
ATP receptors (purinoceptors) on oligodendrocytes,
namely P2Y1 and P2Y12 subtypes, which are prosurvival
and maintain myelin integrity (Butt et al. 2014). However,
in hypoxia/ischemia excessive release of ATP by astro-
cytes would activate oligodendroglial P2X7 receptors,
which would cause myelin destruction (Matute et al. 2007),
and blockade of Kir4.1/Kir5.1 may be a therapeutic target
under these pathological conditions.
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